NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,847,798 | +56.2% | 356,285 | +106.6% | 0.08% | +53.8% |
| Q2 2023 | $4,384,391 | -67.1% | 172,478 | -53.2% | 0.05% | -71.3% |
| Q1 2023 | $13,325,107 | +5.7% | 368,606 | +15.8% | 0.18% | +7.1% |
| Q4 2022 | $12,607,214 | -20.1% | 318,364 | -6.0% | 0.17% | -23.5% |
| Q3 2022 | $15,788,000 | -27.0% | 338,790 | -31.4% | 0.22% | -33.6% |
| Q2 2022 | $21,641,000 | +8.1% | 493,741 | +78.3% | 0.33% | +2.5% |
| Q1 2022 | $20,027,000 | +149.5% | 276,881 | +179.7% | 0.32% | +182.6% |
| Q4 2021 | $8,026,000 | -57.9% | 99,005 | -39.6% | 0.12% | -63.0% |
| Q3 2021 | $19,068,000 | +3010.6% | 163,842 | +4329.4% | 0.31% | +2727.3% |
| Q2 2021 | $613,000 | -92.5% | 3,699 | -94.7% | 0.01% | -96.7% |
| Q4 2019 | $8,138,000 | – | 69,233 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |